EULAV Asset Management’s Core Laboratories CLB Stock Holding History

EULAV Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,700	Closed	-$641K	–	276
2016 Q1	$641K	Sell	5,700 -13,000	-70%	-$1.35M	0.04%	258
2015 Q4	$2.03M	Hold	18,700	–	–	0.11%	212
2015 Q3	$1.87M	Sell	18,700 -1,000	-5%	-$109K	0.11%	227
2015 Q2	$2.25M	Hold	19,700	–	–	0.12%	233
2015 Q1	$2.06M	Hold	19,700	–	–	0.11%	237
2014 Q4	$2.37M	Sell	19,700 -3,000	-13%	-$394K	0.13%	223
2014 Q3	$3.32M	Hold	22,700	–	–	0.18%	180
2014 Q2	$3.79M	Hold	22,700	–	–	0.2%	160
2014 Q1	$4.5M	Buy	22,700 +600	+3%	+$113K	0.25%	149
2013 Q4	$4.22M	Hold	22,100	–	–	0.23%	155
2013 Q3	$3.74M	Buy	22,100 +3,000	+16%	+$466K	0.22%	162
2013 Q2	$2.9M	Buy	+19,100	New	+$2.71M	0.18%	190

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

EULAV Asset Management's CLB Position: Q2 2016 in Review

EULAV Asset Management sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 5,700 shares — an estimated $641K sold.

EULAV Asset Management first reported a position in CLB in Q2 2013 and held it in 12 quarters. The position peaked at $4.5M in Q1 2014. 383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

EULAV Asset Management reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
EULAV Asset Management sold 5,700 Core Laboratories shares in Q2 2016, an estimated $641K.
EULAV Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 12 quarters.
EULAV Asset Management's Core Laboratories position peaked at $4.5M in Q1 2014.
383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on EULAV Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.